REFERENCES
- Karam H, Bruneval P, Clozel JP, Loffler BM, Bariety J, Clozel M. Role of endothelin in acute renal failure due to rhabdomyolysis in rats. J Pharmacol Exp Ther. 1995; 274(1)481–486
- Venkatachalam MA, Rennke HG, Sandstrom DJ. The vascular basis for acute renal failure in the rat. Preglomerular and postglomerular vasoconstriction. Circ Res. 1976; 38(4)267–279
- Yanagisawa H, Nodera M, Umemori Y, Shimoguchi Y, Wada O. Role of angiotensin II, endothelin-1, and nitric oxide in HgCl2-induced acute renal failure. Toxicol Appl Pharmacol. 1998; 152(2)315–326
- Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanism in toxic acute renal failure. Drug Metab Rev. 1999; 31(4)971–997
- Shah SV, Walker PD. Reactive oxygen metabolites in toxic acute renal failure. Ren Fail. 1992; 14(3)363–370
- Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996; 49: 314–326
- Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Nat Acad Sci 1997; 94: 4312–4317
- Law RE, Goetze S, Xi XP, Jackson S, Kawano Y, Demer L, Fishbein MC, Meehan WP, Hsuch WA. Expression and function of PPARγ in rat and human vascular smooth muscle cells. Circulation. 2000; 101: 1311–1318
- Marx N, Duez H, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors and atherogenesis: Regulator of gene expression in vascular cells. Circ Res. 2004; 94: 1168–1178
- Touyz RM, Schiffrin EL. Peroxisome proliferator activated receptors in vascular biology-molecular mechanism and clinical implications. Vascul Pharmacol. 2006; 45(1)19–28
- Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Kudo M, Sato K, Taniyama Y, Ito S. Transcriptional suppression of type-1 angiotensin II receptor gene expression by peroxisome proliferator activated receptor gamma in vascular smooth muscle cells. Endocrinology. 2001; 142(7)3125–3134
- Ogihara T, Rakugi H, Ikegami H, Mikami H, Masuo K. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens. 1995; 8: 316–320
- Imano E, Kanda T, Nakatani Y, Nishida TM, Arai K, Motomura M, Kajimoto Y, Yamasaki Y, Hori M. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Diabetes Care. 1998; 21: 2135–2139
- Zager RA. Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest. 1992; 90(3)711–719
- Itoh H, Doi K, Tanaka T, Fukunaga Y, Hosoda K, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Nakao K. Hypertension and insulin resistance: role of peroxisome proliferator activates receptor gamma. Clin Exp Pharmacol Physiol. 1999; 26(7)558–560
- Newaz MA, Yousefipour Z, Oyekan AO. Role of PPARγ on the pathogenesis and vascular changes in glycerol-induced acute renal failure. J Pharmacological Research. 2006; 54(3)234–240
- Juranek I, Bezek S. Controversy of free radical hypothesis: reactive oxygen species—cause or consequence of tissue injury?. Gen Physiol Biophys. 2005 Sep; 24(3)263–278
- Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res. Nov, 2005; 33(5)349–357, E-pub 2005 Nov 15.
- Chander V, Chopra K. Protective effect of resveratrol, a polyphenolic phytoalexin on glycerol-induced acute renal failure in rat kidney. Ren Fail. 2006; 28(2)161–169
- Newaz MA, Oyekan AO. Vascular responses to endothelin-1, angiotensin-II, and U46619 in glycerol-induced renal failure. J Cardiovasc Pharmacol. 2001; 38(4)569–577
- Martindale JL, Holbrook NJ. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol. 2002; 192(1)1–15
- Arakawa K, Urata H. Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis. Hypertension. 2000; 36(4)638–641
- Tu B, Gong JP, Feng HY, Wu CX, Shi YJ, Li XH, Peng Y, Liu CA, Li SW. Role of NF-kB in multiple organ dysfunction during acute obstructive cholangitis. World J Gastroenterol. 2003; 9(1)179–183
- Cao CC, Ding XQ, Ou ZL, Liu CF, Li P, Wang L, Zhu CF. [Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats]. Zhonghua Yi Xue Za Zhi. 2003; 83(18)1597–1602
- Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Rad Biol Med. 1997; 22(1–2)269–285
- Soares T, de J, Costa RS, Balbi APC, Coimbra TM. Inhibition of nuclear factor-kappa B activation reduces glycerol-induced renal injury. J Nephrol 2006; 19: 439–448